Exemestane 25 MG trials for Breast cancer

All Exemestane 25 MG trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Exemestane 25 MG for Breast cancer

• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
  NCT05512364 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 112 locations
• Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.
  NCT06364267 · Phase: Phase 2 · Ages: No age limits stated · Sex: Female · 1 location
• Sapu003 in Advanced mTOR-sensitive Solid Tumors
  NCT07369505 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Exemestane 25 MG for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.